Juha Klefstrom
Helsinki, 00290, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Biomimetic porous silicon for rationally designed combination therapy to induce immunogenic cell death.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: December 10, 2025
Complex I drives glutamine-dependent TCA cycle to support viability of MYChigh breast cancer cells.
Journal: Cell reports
Published: May 30, 2025
Low Hepsin Expression Associates with a Better Response to Gemcitabine-Based Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.
Journal: Oncology
Published: March 12, 2025
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses.
Journal: Oncoimmunology
Published: February 17, 2025
Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling.
Journal: Nature communications
Published: April 26, 2024
Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment.
Journal: Journal for immunotherapy of cancer
Published: March 04, 2024
MYC-an emerging player in mitochondrial diseases.
Journal: Frontiers in cell and developmental biology
Published: July 12, 2023
Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
Journal: Molecular oncology
Published: July 05, 2023
Fibrin Stiffness Regulates Phenotypic Plasticity of Metastatic Breast Cancer Cells.
Journal: Advanced healthcare materials
Published: April 11, 2023
Immunoglobulin superfamily member 3 is required for the vagal neural crest cell migration and enteric neuronal network organization.
Journal: Scientific reports
Published: March 07, 2023
Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axis.
Journal: Molecular oncology
Published: August 22, 2022
Last Updated: 09/26/2026